Baillie Gifford Discloses 9.89% Stake in Guardant Health
Ticker: GH · Form: SC 13G · Filed: Jan 29, 2024 · CIK: 1576280
| Field | Detail |
|---|---|
| Company | Guardant Health, Inc. (GH) |
| Form Type | SC 13G |
| Filed Date | Jan 29, 2024 |
| Risk Level | low |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: institutional-ownership, insider-buy, investment-firm, stake-disclosure
TL;DR
**Baillie Gifford just revealed a huge 9.89% stake in Guardant Health, signaling big institutional confidence.**
AI Summary
Baillie Gifford & Co, a prominent investment management firm, reported on January 29, 2024, that as of December 29, 2023, they beneficially own 10,240,637 shares of Guardant Health, Inc. (GH). This represents 9.89% of Guardant Health's common stock. This significant stake indicates Baillie Gifford's strong conviction in Guardant Health's future, which could signal confidence to other investors and potentially influence the stock's perception.
Why It Matters
A major institutional investor like Baillie Gifford taking a nearly 10% stake can be seen as a vote of confidence, potentially attracting more investor interest and supporting the stock price.
Risk Assessment
Risk Level: low — This filing indicates a significant institutional investment, generally viewed as a positive sign rather than a risk.
Analyst Insight
A smart investor would view this as a positive signal, potentially researching Guardant Health further to understand Baillie Gifford's investment thesis and consider adding to or initiating a position.
Key Numbers
- 10,240,637 — Shares Owned (Total shares of Guardant Health, Inc. beneficially owned by Baillie Gifford & Co.)
- 9.89% — Ownership Percentage (Percentage of Guardant Health, Inc.'s common stock owned by Baillie Gifford & Co.)
Key Players & Entities
- Baillie Gifford & Co (company) — the reporting person and investment management firm
- Guardant Health, Inc. (company) — the subject company whose securities are being reported
- 10,240,637 (dollar_amount) — number of shares beneficially owned by Baillie Gifford & Co
- 9.89% (dollar_amount) — percentage of Guardant Health's common stock owned by Baillie Gifford & Co
- December 29, 2023 (person) — date of the event requiring the filing
- January 29, 2024 (person) — date the SC 13G filing was made
Forward-Looking Statements
- Guardant Health's stock price may see increased stability or upward pressure due to institutional confidence. (Guardant Health, Inc.) — medium confidence, target: next 3-6 months
FAQ
Who is the reporting person in this SC 13G filing?
The reporting person is Baillie Gifford & Co, an investment management firm based in Edinburgh, Scotland, as indicated by the 'FILED BY' section and their business address.
What is the subject company whose shares are being reported?
The subject company is Guardant Health, Inc., a medical laboratories company with its business address at 3100 Hanover Street, Palo Alto, CA, as stated in the 'SUBJECT COMPANY' section.
How many shares of Guardant Health, Inc. does Baillie Gifford & Co beneficially own?
Baillie Gifford & Co beneficially owns 10,240,637 shares of Guardant Health, Inc. common stock, as detailed in the filing's summary of beneficial ownership.
What percentage of Guardant Health, Inc.'s common stock does Baillie Gifford & Co own?
Baillie Gifford & Co owns 9.89% of Guardant Health, Inc.'s common stock, as reported in the filing.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 29, 2023, as specified on the cover page of the Schedule 13G.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on January 29, 2024 by December 29, 2023 regarding Guardant Health, Inc. (GH).